Key result
Antithrombin administration was successfully used to manage andexanet alfa-associated heparin resistance.
Design
Case_report
Authors
Loading...
May warrant antithrombin consideration in andexanet alfa-associated heparin resistance; leaves open need for prospective confirmation.
Case Report
The title suggests that antithrombin administration may be a successful strategy for managing andexanet alfa-associated heparin resistance.
Apostel et al. (2020) conducted a case report in Andexanet alfa-associated heparin resistance. Antithrombin was evaluated. Antithrombin administration was successfully used to manage andexanet alfa-associated heparin resistance.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: